Innenansicht des neuen Reinraumgebäudes zur Produktion von Medizintechnik bei Geistlich

General planning of a new clean room building for medical technology.

Geistlich Pharma AG, Lucerne, is one of the oldest family companies in Switzerland and is the global market leader in regenerative dentistry. Above all, they focus on the development and production of biomaterials. The products manufactured at the Wolhusen site are sold by a total of eleven subsidiary companies and more than 60 distribution partners. As the biotechnology company has set ambitious sales targets for the Chinese market, it was considered necessary to further expand GMP production. For this reason, IE Life Science was tasked with the general planning of a new industrial building, including various clean room systems, which should be connected directly with the existing factory building.

Building contractor:
Geistlich Pharma AG, Wolhusen

Planning and implementation:
IE Life Science

Design and system planning of a clean room building as general planner, as well as the implementation and coordination of the construction project as the design and build contractor

Planning and construction time:
2.5 years

Clean room area:
1,310 m2

Investment amount:
CHF 11 million

Projekt zum Download:
PDF herunterladen

The challenge.

Long-term production planning is becoming increasingly more difficult, particularly in medical technology and the pharmaceutical industry. The dynamics in the globalised medical engineering and biotechnology markets are growing. The competition pressure is also increasing constantly and the specifications from the regulators are becoming more and more restrictive. The objective of the comprehensive construction and clean room planning by IE Life Science was therefore not just an increase of production capacities. Rather, the greatest challenge was being able to react flexibly to newly designed production processes with fully-equipped rooms. In addition, centrally located building services allow easy access to maintain the accessible clean rooms. There is also compliance with the high demands of the clean room planning itself. As well as the strict separation of personnel and material flows, this also includes an airlock design which meets the hygiene requirements. It is also necessary to prevent possible contaminations at the various interfaces of the clean room concept in an effective manner.

The success factors.

IE Life Science was not just able to impress with a high level of clean room competence and comprehensive GMP knowledge but, above all, with its interdisciplinary planning competence and experience with flexible infrastructures for production. This meant that they were able to develop the industrial construction design consistently “inside to outside”. The architectural shells and building structure were only designed after the integral analysis and planning of the operational processes. The super-elevation of the clean room storeys meant that unrestricted accessibility could be ensured and important reserve levels could be created to expand the building services. The hygiene concept was further developed based on existing zoning concepts and the basic principles of the clean room arrangement were implemented consistently. The result is a modern clean room building with flexibly adjustable building services which can be adapted flexibly to future requirements without complex alterations to the structure.

2.5 years

from clean room concept to complete industrial building


a production infrastructure which can be used and expanded flexibly


the production capacities for current and future products


of the building area is available for future growth


high clean room requirements when expanding GMP production


an efficient bulk production and easy access to the fully-equipped rooms

“It was important to us that we find a planning partner who could take on the entire package. A further criterion was comprehensive GMP knowledge. We were able to expect this experience with IE Life Science.”

Cornel Imhof,
Head of Department, Geistlich Pharma AG

Our industry specialists – your direct contact for IE Life Science.

Dr. Stefan Bokorny
Managing Director IE Life Science Zurich

Telephone number
+41 44 389 86 27


    Please call me back

    Preferred date for the callback*

    Preferred time for the callback*

    Contact details




    Telephone number


    Request for information material
    Consent to privacy policy*

    * I hereby authorise IE Group to contact me via e-mail for the purpose of advertising or market and opinion research. IE Group stores and processes your data on the basis of our privacy policy.

    Further successful IE Life Science projects in medical technology and biotechnology.


    Production expansion of a new wet line for the production of high-quality baby food, Nestlé S.A.


    Clean room planning and ventilation concept for the production of medical technology. Stryker Osteosynthesis AG.